The Renaissance of Renal Denervation

Please note: AHA does not associate with, nor endorse YouTube recommendations.
Resistant hypertension affects twenty percent of all hypertensive patients. It is the source of much cardiovascular risk and its ultimate sequela. To this end innovative mechanisms of addressing this problem have and are being developed. One of these is renal denervation of the sympathetic system. Our guests on the podcast compare clinical studies and share success stories for treatment of resistant hypertensive patients.
Recommended Videos
Stroke Risk Calculation and Shared Decision Making in the Management of At...
Overview and Challenges of ARIA
Use of Artificial Intelligence in Improving Outcomes in Heart Disease: EHR...
Mitigating Risks in ARIA for Stroke Patients
Anti-Amyloid Immunotherapy for Patients with Pre-existing Cerebrovascular...
saved video
Save Video

Please note: AHA does not associate with, nor endorse YouTube recommendations.

See Full Content
Video is not available. Please check the URL.